Prediction of Long-term Scalp Hair Regrowth at 24 Months in Patients with Alopecia Areata Receiving Ritlecitinib Treatment in the ALLEGRO Clinical Trial Program. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 2, p. s561, 2025. DOI: 10.25251/skin.10.supp.561. Disponível em: https://skin.dermsquared.com/skin/article/view/3291. Acesso em: 25 oct. 2025.